1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
Asia Pacific Antacids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Dosage Form ; Drug Class ; Distribution Channel

Asia Pacific Antacids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Dosage Form ; Drug Class ; Distribution Channel

  • April 2021
  • 150 pages
  • ID: 6064908
  • Format: PDF
  • The Insight Partners


Table of Contents

Search Inside

The Asia Pacific antacids market is expected to reach US$ 3,255.05 million in 2027 from US$ 2,287.19 million in 2019. The market is estimated to grow at a CAGR of 4.6% during 2020–2027.

The growth of the Asia Pacific antacids market is attributed to the key driving factors such as the increasing launches of innovative products by market players and the rising incidence of obese population. However, the stringent regulatory norms and several challenges associated with gastrointestinal diseases hinder the market growth.

Many players operating in the Asia Pacific antacid market are developing and launching new products.The companies adopt strategies such as new products’ launches to expand their geographic presence and capacity to cater to many customers.

For instance, in October 2020, Dr. Reddy’s Laboratories (an Indian multinational pharmaceutical) launched an over-the-counter (OTC) generic drug—Famotidine tablets—to treat gastroesophageal reflux disease in the market.

Similarly, in May 2017, the consumer products division of Piramal Enterprises, headquartered in Mumbai, India, launched the paan-flavored (betel leaf flavor) variant of its antacid brand, Polycrol.With the pleasant taste, Polycrol offers quick relief from acidity.

Furthermore, one of India’s leading drug makers, Sun Pharmaceuticals Ltd launched Pepmelt (a mouth-melt granules format) in February 2016.This product is the company’s first consumer healthcare product.

Additionally, in May 2017, GSK Consumer Healthcare (a leading global consumer healthcare company) launched “ENO Cooling”—driven by Fast Cooling Technology.The product quickly relieves from acidity and offers an instant cooling sensation.

Therefore, the increasing launches of innovative products associated with antacids drive the growth of the Asia Pacific antacid market.

Countries in the Asia Pacific are facing challenges due to the rapidly increasing number of COVID-19 confirmed cases.The countries in the region expect the second wave of the outbreak due to the large-scale movements of people within the countries and internal travel.

As a precautionary measure, the governments are imposing restrictions on human movements.The governments have preferred to continue to permit business operations and economic activities.

Thus, the supply of the consumer health products such as antacids is less affected.For instance, India is among the largest hubs for pharmaceutical manufacturing.

The country contributes to the majority shares of supplying generic and branded drugs across the world. The manufacturers are operating with full capacity. Thus, it is expected to maintain the gap between the demand and supply of the products in the associated markets. The outbreak has severely affected the tourism industry and imposed supply chain disruptions. Moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent transmission of the coronavirus that causes COVID-19.

Acidity is among the common side effects associated with the medications prescribed for COVID-19 and other chronic diseases. Thus, the demand for antacids is rising during the ongoing COVID-19 outbreak.

Based on dosage form, the Asia Pacific antacids market is segmented into tablet, liquid, and others. The tablet segment held the largest market share in 2019, whereas the liquid segment is anticipated to register the highest CAGR in the market during the forecast period.

The Asia Pacific antacids market, based on drug class, is segmented into proton pump inhibitors, H2 antagonist, and acid neutralizers.The proton pump inhibitors segment held the largest market share in 2019.

Also, the same segment is anticipated to register the highest CAGR in the market during 2020–2027.

By distribution channel, the Asia Pacific antacids market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment held the largest market share in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.

A few of the primary and secondary sources referred to while preparing the report on the Asia Pacific antacids market are National Center for Health Statistics (NCHS), the India Brand Equity Foundation (IBEF), and the Australian Self Medication Industry (ASMI).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market – Analysis By Drug Type, Distribution Channel, By Region, and By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)

  • $ 2400
  • August 2021
  • 200 pages

Executive Summary Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market was valued at USD 5.5 billion in the year 2020. The key factors driving growth in the global Gastroesophageal Reflux ...

  • World
  • APAC
  • Gastrointestinal Drug
  • Therapy
  • Industry analysis
  • Health Expenditure
  • Gross Domestic Product

Digestive Remedies in Bolivia $ 990 September 2021

Digestive Remedies in Mexico $ 990 September 2021


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on